Medicus advances cancer diagnostics through AI-driven biomarker quantification and digital pathology integration.Our platform delivers fast, reproducible, and cell-level accurate scoring, enabling hospitals and biopharma partners to overcome diagnostic bottlenecks and accelerate precision medicine.
The Challenge We Address
Modern pathology remains manual, inconsistent, and strained by rising cancer volumes and limited specialist capacity.Complex biomarkers—PD-L1, HER2, Claudin-18.2—require precise yet time-intensive evaluation, delaying critical treatment decisions.
Our Solution
Built on a 250,000+ expertly annotated slide dataset, Medicus provides high-fidelity AI quantification across major cancer types.Through strong clinical collaborations, we ensure regulatory-ready workflows and smooth adoption in real-world settings.
(회사 로고를 클릭하시면 홈페이지로 이동합니다)